%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Yue Dong, Sebastian Ochsenreither, Chengxuan Cai, Andreas M. Kaufmann, Andreas E. Albers, Xu Qian
Aldehyde dehydrogenase 1 isoenzyme expression as a marker of cancer stem cells correlates to histopathological features in head and neck cancer: A meta-analysis
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 12 0 R/Contents 13 0 R/TrimBox[0 0 612 792]>>
endobj
12 0 obj
[14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R]
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref003)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref005)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref006)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref009)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref010)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref011)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref012)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref013)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref014)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref004)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref015)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref005)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref016)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref017)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref005)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref017)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref018)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref019)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187615.ref020)>>
endobj
33 0 obj
<>/Border[0 0 0]/A 34 0 R>>
endobj
34 0 obj
<>
endobj
13 0 obj
[35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R]
endobj
35 0 obj
<>stream
q
0.83 0.64 0.02 0 k
432.3969 693.2976 m
437.2724 693.2976 l
h
f*
442.5449 693.2976 m
447.4205 693.2976 l
h
f*
458.1354 667.3323 m
463.011 667.3323 l
h
f*
468.2835 667.3323 m
473.1591 667.3323 l
h
f*
338.0598 628.3276 m
347.7543 628.3276 l
h
f*
220.7055 589.3228 m
230.4 589.3228 l
h
f*
242.4189 537.3354 m
252.1701 537.3354 l
h
f*
461.2535 368.3339 m
470.778 368.3339 l
h
f*
526.1669 355.3512 m
535.6913 355.3512 l
h
f*
568.7433 342.3118 m
573.5055 342.3118 l
h
f*
200.0126 329.3291 m
209.537 329.3291 l
h
f*
369.6945 316.3465 m
374.4567 316.3465 l
h
f*
505.5874 316.3465 m
515.1118 316.3465 l
h
f*
519.5906 316.3465 m
529.0583 316.3465 l
h
f*
414.5386 290.3244 m
419.2441 290.3244 l
h
f*
423.7228 290.3244 m
433.2472 290.3244 l
h
f*
331.5402 199.3323 m
341.0646 199.3323 l
h
f*
238.6772 160.3276 m
248.2016 160.3276 l
h
f*
252.6236 160.3276 m
262.148 160.3276 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F7 1 Tf
1 TL
0.007 Tc
0 0 Td
(cell)Tj
1.6043 0 Td
(carcinoma)Tj
4.5468 0 Td
(\(HNSCC\))Tj
4.2803 0 Td
(but)Tj
1.5874 0 Td
(also)Tj
1.8141 0 Td
(proved)Tj
3.0841 0 Td
(being)Tj
2.4888 0 Td
(relevant)Tj
3.5093 0 Td
(for)Tj
1.4173 0 Td
(clinical)Tj
3.1634 0 Td
(outcome)Tj
3.8041 0 Td
(of)Tj
1.0375 0 Td
(patients)Tj
-32.3374 -1.3039 Td
(with)Tj
2.0409 0 Td
(such)Tj
2.1033 0 Td
(a)Tj
0.6633 0 Td
(disease)Tj
3.0954 0 Td
(as)Tj
1.0375 0 Td
(observed)Tj
3.8834 0 Td
(by)Tj
1.2019 0 Td
(our)Tj
1.6611 0 Td
(group)Tj
2.6645 0 Td
(and)Tj
1.7632 0 Td
(others)Tj
2.7722 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
2.6589 0 Td
(HNSCC)Tj
3.583 0 Td
(is)Tj
0.8731 0 Td
(regarded)Tj
3.8494 0 Td
(one)Tj
1.7348 0 Td
(of)Tj
-35.5859 -1.2982 Td
(the)Tj
1.491 0 Td
(most)Tj
2.245 0 Td
(prevalent)Tj
4.0252 0 Td
(malignant)Tj
4.3766 0 Td
(diseases)Tj
3.4583 0 Td
(worldwide.)Tj
4.7848 0 Td
(Multimodal)Tj
5.0853 0 Td
(treatment)Tj
4.2293 0 Td
(strategies)Tj
4.0252 0 Td
(have)Tj
2.0976 0 Td
(sub-)Tj
-35.8183 -1.2983 Td
(stantially)Tj
3.9174 0 Td
(improved)Tj
4.1953 0 Td
(survival)Tj
3.4242 0 Td
(in)Tj
1.0601 0 Td
(patients)Tj
3.4526 0 Td
(with)Tj
2.0409 0 Td
(curative)Tj
3.5093 0 Td
(potential)Tj
3.8608 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(].)Tj
2.6589 0 Td
(However,)Tj
4.1669 0 Td
(treatment)Tj
-32.2864 -1.2983 Td
(decision)Tj
3.6339 0 Td
(in)Tj
1.0545 0 Td
(clinical)Tj
3.1635 0 Td
(routine)Tj
3.2428 0 Td
(especially)Tj
4.1272 0 Td
(for)Tj
1.4173 0 Td
(locally)Tj
2.8573 0 Td
(advanced)Tj
4.0819 0 Td
(\(LA\))Tj
2.1656 0 Td
(HNSCC)Tj
3.583 0 Td
(remains)Tj
3.5206 0 Td
(a)Tj
0.6633 0 Td
(challenge)Tj
-33.5109 -1.3039 Td
(and)Tj
1.7631 0 Td
(is)Tj
0.8674 0 Td
(based)Tj
2.5285 0 Td
(on)Tj
1.2982 0 Td
(conventional)Tj
5.5616 0 Td
(factors)Tj
2.9763 0 Td
(such)Tj
2.1033 0 Td
(as)Tj
1.0375 0 Td
(tumor)Tj
2.8006 0 Td
(stage,)Tj
2.4945 0 Td
(comorbidities)Tj
5.9073 0 Td
(and)Tj
1.7632 0 Td
(a)Tj
0.6633 0 Td
(patient's)Tj
-31.7648 -1.2982 Td
(responses)Tj
4.1895 0 Td
(to)Tj
1.0488 0 Td
(ongoing)Tj
3.6057 0 Td
(treatments)Tj
4.6091 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(].)Tj
2.1316 0 Td
(Among)Tj
3.2995 0 Td
(patients)Tj
3.4526 0 Td
(who)Tj
1.9729 0 Td
(had)Tj
1.7405 0 Td
(LA)Tj
1.4683 0 Td
(diseases)Tj
3.4639 0 Td
(and)Tj
1.7632 0 Td
(even)Tj
2.1146 0 Td
(with)Tj
-34.8602 -1.2983 Td
(similar)Tj
3.0613 0 Td
(histopathological)Tj
7.2397 0 Td
(characteristics,)Tj
6.3099 0 Td
(diversity)Tj
3.7417 0 Td
(in)Tj
1.0601 0 Td
(responses)Tj
4.1896 0 Td
(to)Tj
1.0488 0 Td
(the)Tj
1.5024 0 Td
(same)Tj
2.3017 0 Td
(treatment)Tj
4.2349 0 Td
(regi-)Tj
-34.6901 -1.3039 Td
(men)Tj
2.0409 0 Td
(resulting)Tj
3.8267 0 Td
(also)Tj
1.8142 0 Td
(in)Tj
1.0545 0 Td
(differences)Tj
4.6828 0 Td
(in)Tj
1.0601 0 Td
(prognosis)Tj
4.218 0 Td
(suggests)Tj
3.5716 0 Td
(so)Tj
1.1055 0 Td
(far)Tj
1.3493 0 Td
(unknown)Tj
4.1555 0 Td
(determining)Tj
5.3008 0 Td
(parame-)Tj
-34.1799 -1.2983 Td
(ters)Tj
1.7177 0 Td
([)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
2.1317 0 Td
(Thus,)Tj
2.5285 0 Td
(additional)Tj
4.388 0 Td
(stratification)Tj
5.4368 0 Td
(factors)Tj
2.9763 0 Td
(could)Tj
2.5115 0 Td
(augment)Tj
3.8098 0 Td
(the)Tj
1.5023 0 Td
(TNM)Tj
2.4945 0 Td
(staging)Tj
3.1351 0 Td
(system)Tj
3.0047 0 Td
(to)Tj
-35.6369 -1.2983 Td
(improve)Tj
3.6566 0 Td
(prediction)Tj
4.4787 0 Td
(of)Tj
1.0375 0 Td
(long-term)Tj
4.3483 0 Td
(survival.)Tj
3.6624 0 Td
(That)Tj
2.1373 0 Td
(is,)Tj
1.1055 0 Td
(biomarker)Tj
4.5184 0 Td
(stratified)Tj
3.8664 0 Td
(treatment)Tj
4.2349 0 Td
(strategies)Tj
-33.046 -1.3039 Td
(could)Tj
2.5058 0 Td
(become)Tj
3.3902 0 Td
(a)Tj
0.6633 0 Td
(reality.)Tj
3.0274 0 Td
(Although)Tj
4.0932 0 Td
(HNSCC)Tj
3.5829 0 Td
(prognosis,)Tj
4.4617 0 Td
(and)Tj
1.7632 0 Td
(specifically)Tj
4.6998 0 Td
(in)Tj
1.0601 0 Td
(oropharyngeal)Tj
6.1682 0 Td
(can-)Tj
-35.4158 -1.2982 Td
(cer)Tj
1.4683 0 Td
(\(OPSCC\),)Tj
4.3256 0 Td
(has)Tj
1.5704 0 Td
(clearly)Tj
2.897 0 Td
(been)Tj
2.1713 0 Td
(influenced)Tj
4.5524 0 Td
(by)Tj
1.2019 0 Td
(detection)Tj
4.0365 0 Td
(of)Tj
1.0375 0 Td
(human)Tj
3.1351 0 Td
(papilloma)Tj
4.3086 0 Td
(virus)Tj
2.2564 0 Td
(\(HPV\))Tj
-32.961 -1.2983 Td
(infection)Tj
3.8891 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(],)Tj
2.1316 0 Td
(additional)Tj
4.388 0 Td
(biomarkers)Tj
4.8869 0 Td
(are)Tj
1.4853 0 Td
(needed)Tj
3.1578 0 Td
(for)Tj
1.4173 0 Td
(HPV-negative)Tj
6.0435 0 Td
(tumors.)Tj
3.4072 0 Td
(Furthermore,)Tj
5.7429 0 Td
(in)Tj
-36.5496 -1.3039 Td
(case)Tj
1.9048 0 Td
(CSC)Tj
2.0523 0 Td
(have)Tj
2.109 0 Td
(a)Tj
0.6633 0 Td
(predictive)Tj
4.3029 0 Td
(or)Tj
1.1225 0 Td
(prognostic)Tj
4.5921 0 Td
(role)Tj
1.8142 0 Td
(for)Tj
1.4173 0 Td
(patients)Tj
3.4583 0 Td
(with)Tj
2.0409 0 Td
(HNSCC)Tj
3.583 0 Td
(as)Tj
1.0374 0 Td
(suggested)Tj
4.1669 0 Td
(by)Tj
1.2076 0 Td
(pre-)Tj
-35.4725 -1.2983 Td
(clinical)Tj
3.1634 0 Td
(studies,)Tj
3.2995 0 Td
(the)Tj
1.5024 0 Td
(targeting)Tj
3.8891 0 Td
(of)Tj
1.0374 0 Td
(the)Tj
1.5024 0 Td
(CSC)Tj
2.0579 0 Td
(cell)Tj
1.6044 0 Td
(population)Tj
4.6998 0 Td
(in)Tj
1.0545 0 Td
(combination)Tj
5.4709 0 Td
(with)Tj
2.0409 0 Td
(conventional)Tj
-31.3226 -1.2982 Td
(therapies)Tj
3.9401 0 Td
(aiming)Tj
3.0897 0 Td
(at)Tj
0.9751 0 Td
(a)Tj
0.6633 0 Td
(reduction)Tj
4.2123 0 Td
(or)Tj
1.1225 0 Td
(eradication)Tj
4.8416 0 Td
(of)Tj
1.0374 0 Td
(the)Tj
1.5024 0 Td
(bulk)Tj
2.0409 0 Td
(tumor)Tj
2.8006 0 Td
(would)Tj
2.7666 0 Td
(be)Tj
1.1736 0 Td
(a)Tj
0.6633 0 Td
(reasonable)Tj
-30.8294 -1.2983 Td
(approach)Tj
4.0365 0 Td
(to)Tj
1.0488 0 Td
(improve)Tj
3.6566 0 Td
(therapeutic)Tj
4.8529 0 Td
(efficacy)Tj
3.3109 0 Td
(by)Tj
1.2075 0 Td
(prevention)Tj
4.6885 0 Td
(of)Tj
1.0375 0 Td
(local)Tj
2.1316 0 Td
(recurrence)Tj
4.6375 0 Td
(or)Tj
1.1168 0 Td
(metastasis)Tj
-31.7251 -1.3039 Td
(formation.)Tj
-0.004 Tc
1.1962 -1.2983 Td
(CSC)Tj
2.0239 0 Td
(can)Tj
1.6271 0 Td
(be)Tj
1.1508 0 Td
(defined)Tj
3.2258 0 Td
(by)Tj
1.1792 0 Td
(their)Tj
2.109 0 Td
(biological)Tj
4.0932 0 Td
(features)Tj
3.3449 0 Td
(like)Tj
1.6554 0 Td
(unlimited)Tj
4.1442 0 Td
(proliferative)Tj
5.091 0 Td
(capacity,)Tj
3.6964 0 Td
(and)Tj
-34.5371 -1.2983 Td
(enhanced)Tj
4.0761 0 Td
(resistance)Tj
4.1329 0 Td
(to)Tj
1.0262 0 Td
(conventional)Tj
5.4254 0 Td
(treatment)Tj
4.1329 0 Td
(modalities)Tj
4.371 0 Td
(like)Tj
1.6555 0 Td
(chemotherapy)Tj
5.947 0 Td
(or)Tj
1.0998 0 Td
(radiation,)Tj
4.0989 0 Td
(by)Tj
-35.9657 -1.3039 Td
(phenotypical)Tj
5.3857 0 Td
(markers)Tj
3.498 0 Td
(like)Tj
1.6497 0 Td
(receptor)Tj
3.5547 0 Td
(expression,)Tj
4.6941 0 Td
(or)Tj
1.0998 0 Td
(by)Tj
1.1792 0 Td
(indirect)Tj
3.3449 0 Td
(detection)Tj
3.9401 0 Td
(of)Tj
1.0148 0 Td
(specific)Tj
3.1918 0 Td
(transmem-)Tj
-32.5528 -1.2982 Td
(brane)Tj
2.5058 0 Td
(transporter)Tj
4.7168 0 Td
(molecules.)Tj
4.4277 0 Td
(Among)Tj
3.2428 0 Td
(these)Tj
2.2563 0 Td
(CSC)Tj
2.0183 0 Td
(markers,)Tj
3.7247 0 Td
(the)Tj
1.4683 0 Td
(aldehyde)Tj
3.7871 0 Td
(dehydrogenase)Tj
6.2135 0 Td
(1)Tj
-34.3613 -1.2983 Td
(\(ALDH1\))Tj
4.0988 0 Td
(isoenzymes,)Tj
5.0287 0 Td
(which)Tj
2.6475 0 Td
(can)Tj
1.6271 0 Td
(be)Tj
1.1508 0 Td
(detected)Tj
3.566 0 Td
(by)Tj
1.1792 0 Td
(their)Tj
2.109 0 Td
(enzymatic)Tj
4.3029 0 Td
(function)Tj
3.6283 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8199 0 Td
(as)Tj
1.0148 0 Td
(by)Tj
1.1848 0 Td
(immu-)Tj
-34.3726 -1.3039 Td
(nohistochemistry,)Tj
7.4097 0 Td
(are)Tj
1.4456 0 Td
(well)Tj
1.8199 0 Td
(studied)Tj
3.1521 0 Td
(in)Tj
1.0374 0 Td
(HNSCC.)Tj
3.7531 0 Td
(ALDH1)Tj
3.4185 0 Td
(is)Tj
0.8504 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
0.652 0 Td
(stem)Tj
2.126 0 Td
(cell-like)Tj
3.3448 0 Td
(phe-)Tj
-35.2627 -1.2983 Td
(notype,)Tj
3.1917 0 Td
(which)Tj
2.6533 0 Td
(is)Tj
0.8447 0 Td
(among)Tj
2.999 0 Td
(other)Tj
2.3471 0 Td
(mechanisms)Tj
5.2044 0 Td
(a)Tj
0.6519 0 Td
(direct)Tj
2.5342 0 Td
(consequence)Tj
5.3347 0 Td
(of)Tj
1.0148 0 Td
(its)Tj
1.1452 0 Td
(obvious)Tj
3.3562 0 Td
(activity)Tj
3.1125 0 Td
(for)Tj
-34.3897 -1.2983 Td
(oxidation)Tj
4.0421 0 Td
(of)Tj
1.0148 0 Td
(retinal)Tj
2.8063 0 Td
(to)Tj
1.0261 0 Td
(retinoic)Tj
3.3279 0 Td
(acid)Tj
1.8709 0 Td
(leading)Tj
3.135 0 Td
(to)Tj
1.0205 0 Td
(cell)Tj
1.5591 0 Td
(differentiation)Tj
5.981 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(].)Tj
2.075 0 Td
(Furthermore,)Tj
5.6182 0 Td
(ALDH1)Tj
-33.4769 -1.2982 Td
(expression)Tj
4.4617 0 Td
(enhances)Tj
3.9117 0 Td
(resistance)Tj
4.1329 0 Td
(to)Tj
1.0262 0 Td
(several)Tj
2.931 0 Td
(anticancer)Tj
4.3936 0 Td
(drugs)Tj
2.4718 0 Td
(by)Tj
1.1849 0 Td
(its)Tj
1.1452 0 Td
(catalytic)Tj
3.4979 0 Td
(activity)Tj
3.1181 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
2.0806 0 Td
(In)Tj
1.1055 0 Td
(cell)Tj
-35.4611 -1.3039 Td
(lines,)Tj
2.2903 0 Td
(ALDH1-positivity)Tj
7.4664 0 Td
(is)Tj
0.8448 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
1.9955 0 Td
(tumorigenesis)Tj
5.8621 0 Td
(and)Tj
1.7347 0 Td
(resistance)Tj
4.1273 0 Td
(to)Tj
1.0261 0 Td
(chemo-radiation)Tj
6.9278 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
-36.5326 -1.2983 Td
(15)Tj
0 g
(].)Tj
1.7347 0 Td
(ALDH1A1)Tj
4.5808 0 Td
(positive)Tj
3.3165 0 Td
(CSCs)Tj
2.3868 0 Td
(are)Tj
1.4456 0 Td
(found)Tj
2.6192 0 Td
(both)Tj
2.058 0 Td
(in)Tj
1.0374 0 Td
(primary)Tj
3.4583 0 Td
(tumors)Tj
3.1011 0 Td
(originating)Tj
4.6601 0 Td
(from)Tj
2.2053 0 Td
(the)Tj
1.4684 0 Td
(oral)Tj
1.7801 0 Td
(cav-)Tj
-35.8523 -1.2983 Td
(ity,)Tj
1.4626 0 Td
(oropharynx,)Tj
5.1534 0 Td
(hypopharynx)Tj
5.5445 0 Td
(and)Tj
1.7291 0 Td
(larynx)Tj
2.7383 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(])Tj
1.3776 0 Td
(and)Tj
1.7291 0 Td
(in)Tj
1.0375 0 Td
(lymph)Tj
2.7836 0 Td
(node)Tj
2.228 0 Td
(metastases)Tj
4.4334 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7404 0 Td
(17)Tj
0 g
(].)Tj
1.7348 0 Td
(Clinical)Tj
-33.6923 -1.3039 Td
(studies)Tj
2.9876 0 Td
(have)Tj
2.058 0 Td
(shown)Tj
2.846 0 Td
(the)Tj
1.474 0 Td
(prognostic)Tj
4.4843 0 Td
(value)Tj
2.3074 0 Td
(of)Tj
1.0148 0 Td
(ALDH1A1)Tj
4.5808 0 Td
(in)Tj
1.0318 0 Td
(patients)Tj
3.3732 0 Td
(with)Tj
1.9956 0 Td
(LA)Tj
1.44 0 Td
(HNSCC)Tj
3.5262 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8199 0 Td
(as)Tj
-35.9544 -1.2982 Td
(in)Tj
1.0318 0 Td
(patients)Tj
3.3732 0 Td
(with)Tj
1.9955 0 Td
(nodal)Tj
2.4832 0 Td
(and)Tj
1.7291 0 Td
(visceral)Tj
3.2031 0 Td
(metastatic)Tj
4.2746 0 Td
(disease)Tj
3.0218 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2585 0 Td
(17)Tj
0 g
(].)Tj
-21.1746 -1.2983 Td
(Because)Tj
3.3958 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(persistence)Tj
4.6374 0 Td
(of)Tj
1.0148 0 Td
(CSC)Tj
2.024 0 Td
(during)Tj
2.9253 0 Td
(therapy,)Tj
3.4752 0 Td
(which)Tj
2.6476 0 Td
(contributes)Tj
4.7565 0 Td
(to)Tj
1.0261 0 Td
(tumor)Tj
2.7439 0 Td
(relapse)Tj
2.9934 0 Td
(and)Tj
-35.3194 -1.3039 Td
(its)Tj
1.1451 0 Td
(capacity)Tj
3.4696 0 Td
(for)Tj
1.389 0 Td
(recapitulation)Tj
5.7826 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(heterogeneous)Tj
6.0321 0 Td
(features)Tj
3.3448 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(cancer,)Tj
3.0727 0 Td
(eradication)Tj
4.7225 0 Td
(of)Tj
1.0148 0 Td
(CSC)Tj
2.0239 0 Td
(is)Tj
-36.1471 -1.2983 Td
(viewed)Tj
2.999 0 Td
(as)Tj
1.0148 0 Td
(an)Tj
1.2019 0 Td
(important)Tj
4.2803 0 Td
(challenge)Tj
3.9628 0 Td
(for)Tj
1.3833 0 Td
(a)Tj
0.6576 0 Td
(successful)Tj
4.1612 0 Td
(cancer)Tj
2.846 0 Td
(therapy.)Tj
3.4696 0 Td
(In)Tj
1.1112 0 Td
(a)Tj
0.6519 0 Td
(recent)Tj
/F11 1 Tf
2.7099 0 Td
[()1()]TJ
1.0772 0 Td
[()-13()15()3()]TJ
/F7 1 Tf
1.8198 0 Td
(study,)Tj
-33.3465 -1.2983 Td
(NCT-501,)Tj
4.2349 0 Td
(a)Tj
0.6519 0 Td
(theophylline-based)Tj
7.8123 0 Td
(inhibitor)Tj
3.7814 0 Td
(of)Tj
1.0148 0 Td
(ALDH1A1,)Tj
4.8075 0 Td
(was)Tj
1.6951 0 Td
(able)Tj
1.8312 0 Td
(to)Tj
1.0261 0 Td
(overcome)Tj
4.1499 0 Td
(secondary)Tj
4.269 0 Td
(resis-)Tj
-35.2741 -1.3039 Td
(tance)Tj
2.347 0 Td
(to)Tj
1.0262 0 Td
(several)Tj
2.931 0 Td
(chemotherapeutic)Tj
7.438 0 Td
(agents.)Tj
2.9707 0 Td
(The)Tj
1.7858 0 Td
(combination)Tj
5.3461 0 Td
(with)Tj
1.9956 0 Td
(cisplatin)Tj
3.583 0 Td
(treatment)Tj
4.1385 0 Td
(was)Tj
-33.5619 -1.2982 Td
(found)Tj
2.6191 0 Td
(to)Tj
1.0262 0 Td
(significantly)Tj
5.0853 0 Td
(decrease)Tj
3.6113 0 Td
(the)Tj
1.4684 0 Td
(proliferation)Tj
5.2667 0 Td
(of)Tj
1.0148 0 Td
(primary)Tj
3.4526 0 Td
(HNSCC)Tj
3.5262 0 Td
(cells)Tj
1.9219 0 Td
(compared)Tj
4.2463 0 Td
(to)Tj
1.0261 0 Td
(treat-)Tj
-34.2649 -1.2983 Td
(ment)Tj
2.3073 0 Td
(with)Tj
2.0013 0 Td
(the)Tj
1.4683 0 Td
(individual)Tj
4.286 0 Td
(agents)Tj
2.7496 0 Td
([)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
2.0806 0 Td
(Moreover,)Tj
4.3937 0 Td
(ALDH1A1)Tj
4.5807 0 Td
(has)Tj
1.5421 0 Td
(been)Tj
2.1259 0 Td
(proven)Tj
3.0387 0 Td
(to)Tj
1.0262 0 Td
(be)Tj
1.1508 0 Td
(immuno-)Tj
-32.7512 -1.2983 Td
(genic)Tj
2.347 0 Td
(and)Tj
1.7291 0 Td
(a)Tj
0.652 0 Td
(target)Tj
2.5115 0 Td
(for)Tj
1.389 0 Td
(cytotoxic)Tj
3.8664 0 Td
(T-cells.)Tj
3.1067 0 Td
(It)Tj
0.8561 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.126 0 Td
(shown)Tj
2.846 0 Td
(that)Tj
1.7801 0 Td
(T-cell)Tj
2.5172 0 Td
(lines)Tj
2.0692 0 Td
(specific)Tj
3.1918 0 Td
(for)Tj
1.3833 0 Td
(MHC)Tj
-33.9134 -1.3039 Td
(class)Tj
2.0466 0 Td
(I-restricted)Tj
4.6714 0 Td
(epitopes)Tj
3.5376 0 Td
(of)Tj
1.0148 0 Td
(ALDH1A1)Tj
4.5808 0 Td
(can)Tj
1.6271 0 Td
(eliminate)Tj
3.9458 0 Td
(ALDH1A1)Tj
4.5807 0 Td
(positive)Tj
3.3165 0 Td
(cancer)Tj
2.846 0 Td
(cells)Tj
1.9219 0 Td
(in)Tj
-34.0892 -1.2983 Td
(HNSCC)Tj
3.5262 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7348 0 Td
(20)Tj
0 g
(].)Tj
1.7348 0 Td
(These)Tj
2.5682 0 Td
(observations)Tj
5.2611 0 Td
(imply)Tj
2.5228 0 Td
(a)Tj
0.6576 0 Td
(clinical)Tj
3.0727 0 Td
(usefulness)Tj
4.2917 0 Td
(of)Tj
1.0148 0 Td
(ALDH1A1)Tj
4.5807 0 Td
(not)Tj
1.5704 0 Td
(only)Tj
1.9786 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
-35.5292 -1.2982 Td
(predictive)Tj
4.1952 0 Td
(biomarker)Tj
4.4163 0 Td
(but)Tj
1.5534 0 Td
(as)Tj
1.0148 0 Td
(potential)Tj
3.7587 0 Td
(target)Tj
2.5115 0 Td
(in)Tj
1.0375 0 Td
(HNSCC.)Tj
-17.2912 -1.3039 Td
(In)Tj
1.1111 0 Td
(order)Tj
2.4208 0 Td
(to)Tj
1.0261 0 Td
(assess)Tj
2.5229 0 Td
(clinical)Tj
3.0727 0 Td
(and)Tj
1.7291 0 Td
(biological)Tj
4.0932 0 Td
(characteristics)Tj
5.9017 0 Td
(such)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(histological)Tj
4.7679 0 Td
(appearance,)Tj
-30.9201 -1.2983 Td
(lymph)Tj
2.7836 0 Td
(node)Tj
2.228 0 Td
(metastasis)Tj
4.2746 0 Td
(and)Tj
1.7348 0 Td
(patient's)Tj
3.583 0 Td
(survival)Tj
3.3335 0 Td
(in)Tj
1.0374 0 Td
(relation)Tj
3.3166 0 Td
(to)Tj
1.0261 0 Td
(ALDH1)Tj
3.4186 0 Td
(expression)Tj
4.4673 0 Td
(in)Tj
1.0375 0 Td
(HNSCC,)Tj
3.7474 0 Td
(we)Tj
-35.9884 -1.2983 Td
(conducted)Tj
4.4276 0 Td
(a)Tj
0.652 0 Td
(systematic)Tj
4.3597 0 Td
(review)Tj
2.8459 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(literature)Tj
3.8834 0 Td
(and)Tj
1.7291 0 Td
(meta-analysis.)Tj
5.879 0 Td
(Strategies)Tj
4.0366 0 Td
(targeting)Tj
3.7927 0 Td
(ALDH1)Tj
-34.0892 -1.3039 Td
(positive)Tj
3.3165 0 Td
(CSC)Tj
2.0182 0 Td
(are)Tj
1.4513 0 Td
(also)Tj
1.7689 0 Td
(discussed.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 446.5133 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(ALDH1)Tj
3.3945 0 Td
(CSC)Tj
2.3031 0 Td
(in)Tj
0.978 0 Td
(head)Tj
2.4024 0 Td
(and)Tj
1.8567 0 Td
(neck)Tj
2.2961 0 Td
(cancer)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01876)Tj
4.089 0 Td
(15)Tj
0 g
2.0906 0 Td
(November)Tj
4.7622 0 Td
(7,)Tj
1.0418 0 Td
(2017)Tj
33.1018 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(13)Tj
/F8 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F9 1 Tf
0.4819 0 Td
(The)Tj
1.5875 0 Td
(authors)Tj
3.0401 0 Td
(have)Tj
1.963 0 Td
(declared)Tj
-14.7827 -1.3748 Td
(that)Tj
1.6228 0 Td
(no)Tj
1.1693 0 Td
(competing)Tj
4.1599 0 Td
(interests)Tj
ET
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
BT
10.3394 82.7156 Td
(exist.)Tj
ET
Q
endstream
endobj
52 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 56 0 R/Contents 57 0 R/TrimBox[0 0 612 792]>>
endobj
54 0 obj
<>
endobj
58 0 obj
<>
endobj
59 0 obj
<>stream
%!PS-AdobeFont-1.0
11 dict begin
/FontName /TeX_CM_Maths_Symbols def
/FontType 1 def
/FontBBox {-20 -958 1114 770} readonly def
/FontMatrix [0.001 0 0 0.001 0 0] readonly def
/PaintType 0 def
/FontInfo 8 dict dup begin
/FullName (TeX_CM_Maths_Symbols) readonly def
/BaseFontName (TeX_CM_Maths_Symbols) def
end def
/Encoding 256 array
0 1 255 {1 index exch /.notdef put} for
dup 0 /C0 put
dup 1 /C1 put
dup 2 /C2 put
dup 3 /C3 put
dup 4 /C4 put
dup 5 /C5 put
dup 6 /C6 put
dup 7 /C7 put
dup 8 /C8 put
dup 9 /C9 put
dup 10 /C10 put
dup 11 /C11 put
dup 12 /C12 put
dup 13 /C13 put
dup 14 /C14 put
dup 15 /C15 put
dup 16 /C16 put
dup 17 /C17 put
dup 18 /C18 put
dup 19 /C19 put
dup 20 /C20 put
dup 21 /C21 put
dup 22 /C22 put
dup 23 /C23 put
dup 24 /C24 put
dup 25 /C25 put
dup 26 /C26 put
dup 27 /C27 put
dup 28 /C28 put
dup 29 /C29 put
dup 30 /C30 put
dup 31 /C31 put
dup 32 /space put
dup 33 /exclam put
dup 34 /quotedbl put
dup 35 /numbersign put
dup 36 /dollar put
dup 37 /percent put
dup 38 /ampersand put
dup 39 /quoteright put
dup 40 /parenleft put
dup 41 /parenright put
dup 42 /asterisk put
dup 43 /plus put
dup 44 /comma put
dup 45 /hyphen put
dup 46 /period put
dup 47 /slash put
dup 48 /zero put
dup 49 /one put
dup 50 /two put
dup 51 /three put
dup 52 /four put
dup 53 /five put
dup 54 /six put
dup 55 /seven put
dup 56 /eight put
dup 57 /nine put
dup 58 /colon put
dup 59 /semicolon put
dup 60 /less put
dup 61 /equal put
dup 62 /greater put
dup 63 /question put
dup 64 /at put
dup 65 /A put
dup 66 /B put
dup 67 /C put
dup 68 /D put
dup 69 /E put
dup 70 /F put
dup 71 /G put
dup 72 /H put
dup 73 /I put
dup 74 /J put
dup 75 /K put
dup 76 /L put
dup 77 /M put
dup 78 /N put
dup 79 /O put
dup 80 /P put
dup 81 /Q put
dup 82 /R put
dup 83 /S put
dup 84 /T put
dup 85 /U put
dup 86 /V put
dup 87 /W put
dup 88 /X put
dup 89 /Y put
dup 90 /Z put
dup 91 /bracketleft put
dup 92 /backslash put
dup 93 /bracketright put
dup 94 /asciicircum put
dup 95 /underscore put
dup 96 /quoteleft put
dup 97 /a put
dup 98 /b put
dup 99 /c put
dup 100 /d put
dup 101 /e put
dup 102 /f put
dup 103 /g put
dup 104 /h put
dup 105 /i put
dup 106 /j put
dup 107 /k put
dup 108 /l put
dup 109 /m put
dup 110 /n put
dup 111 /o put
dup 112 /p put
dup 113 /q put
dup 114 /r put
dup 115 /s put
dup 116 /t put
dup 117 /u put
dup 118 /v put
dup 119 /w put
dup 120 /x put
dup 121 /y put
dup 122 /z put
dup 123 /braceleft put
dup 124 /bar put
dup 125 /braceright put
dup 126 /asciitilde put
dup 127 /Euro put
dup 128 /ff put
dup 129 /ffi put
dup 130 /ffl put
dup 131 /C131 put
dup 132 /Eth put
dup 133 /eth put
dup 134 /Thorn put
dup 135 /thorn put
dup 136 /onequarter put
dup 137 /onehalf put
dup 138 /C138 put
readonly def
currentdict end
currentfile eexec
M#1H5 J6o\&rtS(#v\0\V7Fe༙OYx5-cY9^%Y6
(efIOldN"wȰ;)UƽoFg/rvV$JS8_oc@
o9-eGJp}[Do]mN=4*{ܯq=eU^t6¤(HwK7X7
Mr:E%]3<Ӝ$wrAQ4ADt%̏>E hAجm*pu@>#6aZi}NRmƼ%
,OgX' EX?ڞ\#JEG<IXS}Eh[ş8ї48ٶ.w4bJ?_nfulqD?둓\C%+' { L9K7isW+ӕ(6oɧVҺlS;5K
Z%.oQՕW*9Qk_S+B-}%lYC@WP0b\KKdi>t,n_S[ '9`-z+cڦEb#c@;yɸoAT O_H~i -6ϰ豟Ae&BF+
wNX!=hhUF8(hZ6pgJc m'9dx*^wXc
գ<.쯶c ln)/LvXY2jbF:ȸ3'>\Ȥmzj,!:ZK' (q/ -&&S ؤ-bm KQSxLGu `D3yԱKaVMU§ %iq5%s 2SdR#ho45H.4TdՊa<K>BqG- Ao, (e&F2gG`z8*༠&
x#B
B;8!93~T/ \>nLazCSKm~,!_<ӾX@X@N2vEt בFmBYa wRG[i;+oM+%(8 jԀlIW>t